Literature DB >> 31527372

Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Lloyd Tanner1, Andrew Bruce Single2.   

Abstract

Chronic obstructive pulmonary disease (COPD) affects the lives of an ever-growing number of people worldwide. The lack of understanding surrounding the pathophysiology of the disease and its progression has led to COPD becoming the third leading cause of death worldwide. COPD is incurable, with current treatments only addressing associated symptoms and sometimes slowing its progression, thus highlighting the need to develop novel treatments. However, this has been limited by the lack of experimental standardization within the respiratory disease research area. A lack of coherent animal models that accurately represent all aspects of COPD clinical presentation makes the translation of promising in vitrodata to human clinical trials exceptionally challenging. Here, we review current knowledge within the COPD research field, with a focus on current COPD animal models. Moreover, we include a set of advantages and disadvantages for the selection of pre-clinical models for the identification of novel COPD treatments.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Animal models; Chronic obstructive pulmonary disease; Fibrosis; Inflammation; Treatment

Mesh:

Year:  2019        PMID: 31527372      PMCID: PMC7265725          DOI: 10.1159/000502489

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  315 in total

Review 1.  Global burden of COPD: risk factors, prevalence, and future trends.

Authors:  David M Mannino; A Sonia Buist
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

2.  GOLD 2019: a new way forward.

Authors:  MeiLan K Han
Journal:  Lancet Respir Med       Date:  2018-11-23       Impact factor: 30.700

3.  Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?

Authors:  Roberto Rodriguez-Roisin; MeiLan K Han; Jørgen Vestbo; Jadwiga A Wedzicha; Prescott G Woodruff; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

4.  A Novel Animal Model of Emphysema Induced by Anti-Elastin Autoimmunity.

Authors:  Bon-Hee Gu; Maran L Sprouse; Matthew C Madison; Monica J Hong; Xiaoyi Yuan; Hui-Ying Tung; Cameron T Landers; Li-Zhen Song; David B Corry; Maria Bettini; Farrah Kheradmand
Journal:  J Immunol       Date:  2019-06-10       Impact factor: 5.422

5.  A simple method for accurate endotracheal placement of an intubation tube in Guinea pigs to assess lung injury following chemical exposure.

Authors:  M P Nambiar; R K Gordon; T S Moran; S M Richards; A M Sciuto
Journal:  Toxicol Mech Methods       Date:  2007       Impact factor: 2.987

6.  Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits.

Authors:  Le-Ling Gan; Min-Wei Wang; Mao-Sheng Cheng; Li Pan
Journal:  Biol Pharm Bull       Date:  2003-03       Impact factor: 2.233

Review 7.  The rabbit as a model for studying lung disease and stem cell therapy.

Authors:  Nurfatin Asyikhin Kamaruzaman; Egi Kardia; Nurulain 'Atikah Kamaldin; Ahmad Zaeri Latahir; Badrul Hisham Yahaya
Journal:  Biomed Res Int       Date:  2013-04-08       Impact factor: 3.411

8.  Pharmacological inhibition of GSK-3 in a guinea pig model of LPS-induced pulmonary inflammation: I. Effects on lung remodeling and pathology.

Authors:  Hoeke A Baarsma; Sophie Bos; Herman Meurs; Kim H Visser; Marieke Smit; Annemie M W J Schols; Ramon C Langen; Huib A M Kerstjens; Reinoud Gosens
Journal:  Respir Res       Date:  2013-10-23

Review 9.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

Review 10.  COPD exacerbations: defining their cause and prevention.

Authors:  Jadwiga A Wedzicha; Terence A R Seemungal
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

View more
  13 in total

1.  Modelers Modelling Models.

Authors:  Arne Egesten; Heiko Herwald
Journal:  J Innate Immun       Date:  2021-03-19       Impact factor: 7.349

2.  Reineckia carnea Alleviates the Production of Inflammatory Cytokines and MUC5AC in Rats with Chronic Obstructive Pulmonary Disease.

Authors:  Wei Liu; Jiang Li; Tongyao Li; Youliang Xie; Caihong Luo
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-16       Impact factor: 2.650

Review 3.  Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models.

Authors:  Luigino Calzetta; Elena Pistocchini; Beatrice Ludovica Ritondo; Francesco Cavalli; Francesca Camardelli; Paola Rogliani
Journal:  Heliyon       Date:  2022-06-22

4.  Quercetin Improves Pulmonary Function and Prevents Emphysema Caused by Exposure to Cigarette Smoke in Male Mice.

Authors:  Natália Pereira da Silva Araújo; Natália Alves de Matos; Michel Oliveira; Ana Beatriz Farias de Souza; Thalles de Freitas Castro; Pedro Alves Machado-Júnior; Débora Maria Soares de Souza; André Talvani; Sílvia Dantas Cangussú; Rodrigo Cunha Alvim de Menezes; Frank Silva Bezerra
Journal:  Antioxidants (Basel)       Date:  2022-01-18

5.  Once upon a Time.

Authors: 
Journal:  J Innate Immun       Date:  2020-05-15       Impact factor: 7.349

Review 6.  Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium.

Authors:  Kai Sen Tan; Rachel Liyu Lim; Jing Liu; Hsiao Hui Ong; Vivian Jiayi Tan; Hui Fang Lim; Kian Fan Chung; Ian M Adcock; Vincent T Chow; De Yun Wang
Journal:  Front Cell Dev Biol       Date:  2020-02-25

Review 7.  Understanding and Treating Niemann-Pick Type C Disease: Models Matter.

Authors:  Valentina Pallottini; Frank W Pfrieger
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

8.  Determining Pharmacological Mechanisms of Chinese Incompatible Herbs Fuzi and Banxia in Chronic Obstructive Pulmonary Disease: A Systems Pharmacology-Based Study.

Authors:  Kaiwen Ni; Xiaolu Cai; Yaling Chen; Linshui Zhou; Ruilin Chen; Suqun Zheng; Zhen Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-31       Impact factor: 2.629

Review 9.  Cell Type-Specific Roles of STAT3 Signaling in the Pathogenesis and Progression of K-ras Mutant Lung Adenocarcinoma.

Authors:  Michael J Clowers; Seyed Javad Moghaddam
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

Review 10.  Targeting COPD with PLGA-Based Nanoparticles: Current Status and Prospects.

Authors:  Juhi Saxena; Monish Bisen; Aditya Misra; Vijay Kumar Srivastava; Sanket Kaushik; Arif Jamal Siddiqui; Neetu Mishra; Abhijeet Singh; Anupam Jyoti
Journal:  Biomed Res Int       Date:  2022-03-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.